Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

Clinical trial NCT05409261 · UNKNOWN

Trial details

NCT number: NCT05409261
Sponsor: ANRS, Emerging Infectious Diseases
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Vaccine Reaction SARS CoV 2 Infection Vaccine Adverse Reaction

Start date: 2022-06-02
Primary completion: 2022-09-25
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.